Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report

Clin Case Rep. 2021 Oct 6;9(10):e04903. doi: 10.1002/ccr3.4903. eCollection 2021 Oct.


Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.

Keywords: interferon; low dose; polycythemia vera.

Publication types

  • Case Reports